Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | +1.53% |
|
+4.48% | -1.06% |
06-27 | Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target | MT |
06-24 | Sophia Genetics S. A. Launches New Residual Acute Myeloid Application | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.06% | 300M | |
+22.53% | 3,414B | |
+17.88% | 93.41B | |
+15.82% | 86.85B | |
+50.55% | 57.52B | |
-20.29% | 48.67B | |
+38.23% | 48.1B | |
-23.39% | 47.45B | |
+76.52% | 40.4B | |
-4.63% | 27.06B |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- Morgan Stanley Trims Price Target on Sophia Genetics to $10 From $11, Maintains Overweight Rating